Skip to main content
Log in

Misonidazole neurotoxicity in rats: Part 11

Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat

  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Summary

Rats pretreated for 5 days with 50 mg/ kg of pentobarbital tolerated statistically significant higher doses of misonidazole before the onset of misonidazole-induced neurotoxicity than rats treated intermittently with the same dose of pentobarbital. Presumably in pretreated rats, pentobarbital induced an increase in the activities of hepatic microsomal enzymes that led to a more rapid metabolism of misonidazole than in rats treated only intermittently.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bobbin RP, May JG, Lemoine RL: Effects of pentobarbital and ketamine on brain stem auditory potentials. Arch Otolaryngol 105:467–470, 1979.

    Google Scholar 

  2. Edwards MSB, Bolger CA, Phillips TL, Levin VA, Jewett DL: Evaluation of misonidazole peripheral neurotoxicity in rats by analysis of nerve trains evoked response. Int J Radiol Oncol Biol Phys 8:69–74, 1982.

    Google Scholar 

  3. Edwards MSB, Powers SK, Baringer RA, Jewett DL, Bolger C, Phillips TL: Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials. J Neuro-Oncol 1:115–123, 1983.

    Google Scholar 

  4. Edwards MSB, Gordon DG, Levin VA, Phillips TL: Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials. J Neuro-Oncol 2:91–94, 1984.

    Google Scholar 

  5. Mead PB, Gibson M, Schentag JJ, Ziemniak JA: Possible alteration of metronidazole metabolism by phenobarbital. N Eng J Med 306:1490, 1982.

    Google Scholar 

  6. Moore JC, Paterson ICM, Newman H, Venables S: Pheyntoin-induced changes in pharmacokinetics of misonidazole in radiotherapy patients. Br J Cancer 44:592, 1981.

    Google Scholar 

  7. Powers SK, Edwards MSB, Baringer RA: Evoked potentials in rats with misonidazole neurotoxicity. 11. Somatosensory evoked potentials. J Neuro-Oncol 1:125–130, 1983.

    Google Scholar 

  8. Urtasun RC, Chapman JD, Feldstein ML, Band RP, Rabin HR, Wilson AF, Marynowski B, Starrveld E, Shnitak T: Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer (Suppl III) 37: 271–275, 1978.

    Google Scholar 

  9. Wasserman TH, Phillips TL, Van Raaltee GV, Urtasun RC, Partington J, Kozio,A, Schwade JG, Gangji D, Strong JM: The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol 53:172, 1980.

    Google Scholar 

  10. Workman P: Effects of pretreatment with pentobarbitone and phenytoin on the pharmacokinetics and toxicity of misonidazole in mice. Br J Cancer 40:335–353, 1979.

    Google Scholar 

  11. Workman P, Bleehen NM, Wiltshire CR: Phenytoin shortens the half-life of the hypoxic cell radiosensitizer misonidazole in man: implications for possible reduced toxicity. Br J Cancer 41:302–304, 1980.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Edwards, M.S., Gordon, D.G., Salamy, A. et al. Misonidazole neurotoxicity in rats: Part 11. J Neuro-Oncol 2, 95–98 (1984). https://doi.org/10.1007/BF00177892

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00177892

Keywords

Navigation